Vevo Therapeutics
2 employees
Artificial Intelligence (AI)
Series A · $42.0M
Open positions (2)
Company details
Team Size2
IndustryArtificial Intelligence (AI)
Funding
Total raised
$42.0M
Last stage
Series A
Investors
Amplify Partners
Total raised
$42.0M
Last stage
Series A
Investors
Nima Alidoust
Princeton Ph.D. in computational/quantum chemistry. Previously at McKinsey & Company, Rigetti Computing, and 1QBit (SandboxAQ). Founding CEO of Vevo Therapeutics (now Tahoe).
Johnny Yu
UCSF Ph.D. in Biomedical Sciences. Previously at Biogen, Broad Institute, and Millennium. Built the Mosaic platform during his doctoral work at UCSF in the Goodarzi lab.
Hani Goodarzi
Princeton Ph.D. Associate Professor at UCSF. Co-developed the platform technology licensed by UCSF to Vevo/Tahoe.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.